metformin has been researched along with Presbycusis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Presbycusis: Gradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H | 1 |
| Han, B | 1 |
| Hu, Y | 1 |
| Zhao, X | 1 |
| He, Z | 1 |
| Chen, X | 1 |
| Sun, H | 1 |
| Yuan, J | 1 |
| Li, Y | 1 |
| Yang, X | 1 |
| Kong, W | 1 |
| Kong, WJ | 1 |
1 other study available for metformin and Presbycusis
| Article | Year |
|---|---|
Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Antioxidants; Apoptosis; Auditory Cortex; Disease Mod | 2020 |